Academic Medicine Research Institute - AMRI

06/03/2026

Join us as we continue the 2026 Research Grand Rounds (RGR) series on 15 April!

Keen to learn how advances in immune monitoring are reshaping the fight against chronic Hepatitis B Virus (HBV)?

Stay tuned for more details!

Prof Antonio Bertoletti
Asst Prof Nina Le Bert
Clin Assoc Prof Chow Wan Cheng

Duke-NUS Medical School
SingHealth
Singapore General Hospital



Visit Academic Medicine Research Institute - AMRI at https://www.singhealthdukenus.com.sg/research

05/03/2026

The National Research Foundation Singapore (NRF) Competitive Research Programme (CRP) Funding Scheme seeks to foster the formation of multi-disciplinary teams in Singapore to conduct cutting-edge research of relevance to the nation. This allows a coordinated, integrated and sustained way of bringing together complementary research groups Singapore to conduct high-impact research.

The CRP scheme funds use-inspired basic research in all areas of science and technology that demonstrates scientific rigour, novelty and ambition beyond the current state-of-the-art. Research ideas at the intersection of multiple disciplines are encouraged, as are proposals that present clear pathways to future applications with transformative or disruptive impact potential. The proposed research should be motivated by an important need or problem to be solved, rather than being solely curiosity-driven, and should clearly articulate how it will advance knowledge whilst creating opportunities for meaningful real-world applications.

Click to read more on the background, eligibility, and submission or application procedure and evaluation criteria: https://for.sg/nrf-crp-2026



Visit Academic Medicine Research Institute - AMRI at https://www.singhealthdukenus.com.sg/research and watch this space for more grant calls!

05/03/2026

Home blood pressure (HBP) is an important parameter that guides clinicians in managing hypertension in patients. However, in using these records to manage patients, physicians face challenges, particularly regarding access, integration, and interpretation of the records when making clinical decisions.

Researchers from SingHealth Polyclinicsand Duke-NUS Medical School conducted a study, which aimed to summarise existing studies on clinical decision support systems (CDSSs) that use HBP readings to manage patients with hypertension.

They concluded that while CDSSs hold promise for improving hypertension management, gaps remain in their development and implementation. Future efforts should focus on integrating robust frameworks, aligning systems with clinical guidelines, enhancing data integration processes, and addressing usability to maximise effectiveness, adoption, and user satisfaction.

Read more in Journal of Medical Internet Research, JMIR: https://bit.ly/4o9A6Ix

AMC researchers involved: Moosa Aminath Shiwaza, Seng Jun Jie Benjamin, Ng Chirk Jenn



Visit Academic Medicine Research Institute - AMRI at https://www.singhealthdukenus.com.sg/research

04/03/2026

The Communicable Diseases Agency (CDA) is launching the FY2026 Short-Term Fellowship call for applications to facilitate collaborative infectious disease (ID) research between healthcare and research institutions in Singapore and beyond. The fellowship will allow successful local ID researchers to invite potential international collaborators/experts (Overseas Expert) to Singapore for up to 14 days (Incoming Fellowship) or spend up to 14 days overseas on a research training attachment at a leading ID institution (Outgoing Fellowship). All visits must be completed before 31 January 2027.

Click to read more on the background, research scope, eligibility, submission or application procedure, and evaluation criteria: https://for.sg/icda-fellowship-fy2026



Visit Academic Medicine Research Institute - AMRI at https://www.singhealthdukenus.com.sg/research and watch this space for more grant calls!

03/03/2026

How are we pushing the frontiers of translational cardiovascular research for patient benefit in Singapore?

At our first Research Grand Rounds of 2026, Prof Derek Hausenloy and Asst Prof Chrishan Ramachandra shared about how CArdiovascular DiseasE National Collaborative Enterprise (CADENCE) and patient-specific induced pluripotent stem cells (iPSCs) disease-modelling platform are accelerating cardiovascular and innovation.

The session was moderated by Prof Wang Yibin from Duke-NUS Medical School.

Thank you to all who had joined us! Catch up on the highlights here: https://for.sg/rgr-25-feb-2026

National Heart Centre Singapore
Duke-NUS Medical School
SingHealth
Cardiovascular Disease National Collaborative Enterprise (CADENCE)

02/03/2026

Celebrating our Clinical Research Community! ❤️

Earlier this month, we came together for SingHealth CRC Day 2026 – an afternoon dedicated to appreciating and celebrating our Clinical Research Coordinators (CRCs) across SingHealth.

From the opening address by Ms Sue Tee, Director of CTCC, to CRC Impact Awards presented by Prof Aung Tin, the programme celebrated the dedication and contributions of our CRCs.

Thank you to all our CRCs for your passion, dedication and commitment to advancing clinical and improving patient care

23/02/2026

One more day to our FIRST Research Grand Rounds of 2026 on Translational Cardiovascular Research for Patient Benefit – Progress through Collaboration! ⏰ – register now at https://for.sg/rgr25feb!

Interested in finding out how CArdiovascular DiseasE National Collaborative Enterprise (CADENCE) and patient-specific induced pluripotent stem cells (iPSCs) disease-modelling platform are accelerating cardiovascular research and innovation?

Join Prof Derek Hausenloy, Asst Prof Chrishan Ramachandra and Prof Wang Yibin as they share how these developments are accelerating cardiovascular and innovation.

Sign up now at https://for.sg/rgr25feb or scan the QR code in the image below!

National Heart Centre Singapore
Duke-NUS Medical School
SingHealth



Visit Academic Medicine Research Institute - AMRI at https://www.singhealthdukenus.com.sg/research

17/02/2026

Wishing everyone a year of abundance, strength and success in all your endeavours! 马年大吉! 🐴

P.S. Fun Fact: Just like the Horse – a symbol of energy, determination and optimism – may our research community continue to push boundaries and advance discoveries that improve lives!

#2026

Visit Academic Medicine Research Institute - AMRI at https://www.singhealthdukenus.com.sg/research

11/02/2026

The progressive loss of dopaminergic neurons in affected patient brains is one of the pathological features of Parkinson’s disease, the second most common human neurodegenerative disease. Although the detailed pathogenesis accounting for dopaminergic neuron degeneration in Parkinson’s disease is still unclear, the advancement of stem cell approaches has shown promise for Parkinson’s disease research and therapy.

Researchers from National Neuroscience Institute and Duke-NUS Medical School discussed the practical approaches and potential applications of induced pluripotent stem cell techniques for generating and differentiating dopaminergic neurons from induced pluripotent stem cells.

They concluded that the discovery of current stem cell techniques for deriving induced pluripotent stem cells (iPSCs) from differentiated cells and further differentiation into distinct lineages of cells has opened new avenues of research, including in the field of neurobiology.

Read more in Neural Regeneration Research, Wolters Kluwer: https://bit.ly/46LlKZ6

AMC researchers involved: Ling-Xiao Yi, Genevieve Saw, Li Zeng, Eng King Tan, Zhi D**g Zhou



Visit Academic Medicine Research Institute - AMRI at https://www.singhealthdukenus.com.sg/research

09/02/2026

Congratulations to Clin Assoc Prof Eugene Wong, Senior Consultant, Gastroenterology and Hepatology at Changi General Hospital (CGH) on achieving this outstanding research milestone. 👏

For years, clinicians have long worried that a group of hepatitis C medicines (protease-inhibitor antivirals) might worsen liver failure in people with advanced cirrhosis, especially since liver transplantation is not available or suitable for many patients worldwide.

In the largest multinational real-world study to date, spanning patients from the USA, Europe, and Asia; Clin Asst Prof Wong and his collaborators helped to close this critical knowledge gap. Their study showed very high cure rates and similar safety outcomes regardless of treatment type, with no increased risk of liver worsening, complications, cancer, or death.

Importantly, the findings suggest that a carefully selected subgroup of patients with decompensated cirrhosis—particularly those with MELD scores below 15—may reasonably consider protease-inhibitor treatment when access to liver transplantation is limited.

This impactful work titled “Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C study” has been recognised as the Best Publication of Hepatology International by the Asia Pacific Association for the Study of Liver (APASL). Clin Asst Prof Wong also recently shared these insights with the global community at the APASL Hepatology Webinar: The Best Publication of Hepatology International.

Read more: https://pubmed.ncbi.nlm.nih.gov/37273170/



Visit Academic Medicine Research Institute - AMRI at https://www.singhealthdukenus.com.sg/research

06/02/2026

Join us as we begin the 2026 RGR series with Translational Cardiovascular Research for Patient Benefit – Progress through Collaboration!

Mark your calendars: 25 Feb 2026, 12.30pm - 1.30pm
Be part of the conversation: https://for.sg/rgr25feb

Swipe through for more and don’t miss the publication recommendations in the comments! 👉📑

Prof Derek Hausenloy
Asst Prof Chrishan Ramachandra
Prof Wang Yibin

National Heart Centre Singapore
Duke-NUS Medical School
SingHealth

Visit Academic Medicine Research Institute - AMRI at https://www.singhealthdukenus.com.sg/research